Clinical Trial Update: Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Ramosetron to Ondansetron for radiotherapy-induced nausea and vomiting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Therapy-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)
• Ramosetron (ramosetron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Radiotherapy Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED